263 related articles for article (PubMed ID: 2533767)
1. [Treatment of myocardial and coronary effects of arterial hypertension].
Strauer BE; Motz W; Vogt M
Z Kardiol; 1989; 78 Suppl 7():231-8. PubMed ID: 2533767
[TBL] [Abstract][Full Text] [Related]
2. Differential therapy of hypertensive heart disease.
Motz WH; Strauer BE
Am J Cardiol; 1990 Apr; 65(14):60G-64G. PubMed ID: 2138859
[TBL] [Abstract][Full Text] [Related]
3. [Coronary microangiopathy in hypertensive heart disease: pathogenesis, diagnosis and therapy].
Motz W; Scheler S; Strauer BE
Herz; 1995 Dec; 20(6):355-64. PubMed ID: 8582695
[TBL] [Abstract][Full Text] [Related]
4. [Benefits and risks of hypertension therapy from the cardiac viewpoint].
Motz W; Strauer BE
Z Kardiol; 1994 Mar; 83(3):179-87. PubMed ID: 8178541
[TBL] [Abstract][Full Text] [Related]
5. [Retrospective studies and prospects of therapy for hypertension].
Maisch B; Brilla C; Kruse T; Noll B; Bethge C
Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment in arterial hypertension for protecting hypertrophic myocardium.
Vogt M; Motz W; Strauer BE
Basic Res Cardiol; 1991; 86 Suppl 3():223-33. PubMed ID: 1838250
[TBL] [Abstract][Full Text] [Related]
7. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
Strauer BE; Bayer F; Brecht HM; Motz W
J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
[TBL] [Abstract][Full Text] [Related]
8. Medical repair of hypertensive left ventricular remodeling.
Motz WH; Scheler S; Strauer BE
J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S32-6. PubMed ID: 1380616
[TBL] [Abstract][Full Text] [Related]
9. [Progression and regression of heart hypertrophy in arterial hypertension: pathophysiology and clinical aspects].
Strauer BE
Z Kardiol; 1985; 74 Suppl 7():171-8. PubMed ID: 2936017
[TBL] [Abstract][Full Text] [Related]
10. [High blood pressure and coronary heart disease. Are there new therapeutic options?].
Motz W
Herz; 2004 May; 29(3):255-65. PubMed ID: 15167951
[TBL] [Abstract][Full Text] [Related]
11. [What is safe in the therapy of hypertensive heart disease?].
Motz W; Strauer BE
Internist (Berl); 1985 Dec; 26(12):750-64. PubMed ID: 2867983
[No Abstract] [Full Text] [Related]
12. Pathophysiology and clinical aspects of hypertensive hypertrophy.
Vogt M; Motz WH; Schwartzkopf B; Strauer BE
Eur Heart J; 1993 Jul; 14 Suppl D():2-7. PubMed ID: 8103741
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
14. The development of coronary insufficiency during prolonged treatment of essential hypertension.
Kalnins UV; Skarda IJ; Liepinja DJ; Vitols AV
Cor Vasa; 1990; 32(1):64-71. PubMed ID: 2140319
[TBL] [Abstract][Full Text] [Related]
15. [Prevention with vasoactive drugs].
Motz W; Vogt M; Scheler S; Schwartzkopff BE; Kelm M; Strauer BE
Z Kardiol; 1992; 81 Suppl 4():199-204. PubMed ID: 1290299
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular structural changes in hypertension: possible regression during long-term antihypertensive treatment.
Novo S; Abrignani MG; Corda M; Strano A
Eur Heart J; 1991 Dec; 12 Suppl G():47-52. PubMed ID: 1839619
[TBL] [Abstract][Full Text] [Related]
17. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
18. [Medicamentous cardioprotection. 2: Hypertension].
Michel D
Fortschr Med; 1990 Feb; 108(6):111-6. PubMed ID: 2138995
[TBL] [Abstract][Full Text] [Related]
19. [The coronary hypertensive: therapeutic principles].
Gosse P; Aouizerate E; Roudaut R; Dallocchio M
Ann Cardiol Angeiol (Paris); 1986; 35(7):397-401. PubMed ID: 2879503
[TBL] [Abstract][Full Text] [Related]
20. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
